Andrew Amiel

Andrew Amiel is an experienced professional in the healthcare and life sciences industry, currently serving as the Vice President of Business Development at Endostart s.r.l.12 His career spans over 14 years, with a strong focus on investment banking, business development, and strategic planning.2

Career Highlights

Current Roles::

• Vice President of Business Development at Endostart s.r.l. (since July 2021)3
• Investor and EVP of Business Development and Investor Relations at Injectsense Inc. (since April 2015)3
• Investor and VP of Business Development and Strategy at LumiThera, Inc. (since June 2016)3

Previous Experience::

• Founded Lamiel Partners in September 2012, a financial advisory firm specializing in healthcare and life sciences3
• Life Sciences Sector Advisor at Go4Venture Advisers (2014-2017)3
• Associate at Landmark Ventures (2010-2012)3
• Analyst at Go4Venture (2008-2009)3

Education

Andrew Amiel attended NYU Stern School of Business from 2005 to 2007, where he obtained a BA degree with a Co-Major in Finance and International Business.1

Expertise

Andrew has demonstrated expertise in:

• Strategic business advice
• Business development
• Finance
• Venture capital
• IPO processes3

Throughout his career, Andrew has been involved in various aspects of the healthcare and life sciences industry, including fundraising, M&A, business development, and market entry strategies, particularly in the Chinese market.13 His experience spans across multiple medical technology companies, contributing to the development and commercialization of innovative treatments and devices.1